Voice of America is currently off the air but may soon partner with One America News, raising concerns about its transformation into a tool for Trump's agenda. Staff members fear for the integrity of journalism at VOA.
The conclave to elect the next pope has begun, with cardinals locked in the Sistine Chapel. Discover what happens next, from secret ballots to the iconic smoke signals announcing the new leader of the Catholic Church.
In a dramatic ruling, U.S. District Judge Royce Lamberth has mandated the restoration of Voice of America and its affiliates, after a controversial shutdown under Trump's directive. Will this decision save independent journalism?
President Trump's latest budget proposal aims to eliminate key funding for the National Endowment for the Arts and Humanities, reviving past attempts to reshape America's cultural landscape. Will Congress approve these drastic cuts?
The Corporation for Public Broadcasting responds to President Trump's executive order to cut funding for NPR and PBS, asserting that Congress controls their funding, not the president. This move has sparked a political outcry.
In a controversial executive order, Trump calls for blocking all federal funding to PBS and NPR, claiming they promote biased news. This move raises concerns about the future of public broadcasting and press freedom.
President Trump has signed an executive order to cut federal funding for NPR and PBS, citing biased reporting. This move could jeopardize local stations, particularly in rural areas, amid ongoing legal battles and political tensions.
In a bold move, President Trump has ordered the cessation of federal funding for NPR and PBS, arguing that taxpayer dollars should not support biased news. This decision raises questions about the future of public broadcasting and journalistic integrity.
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
In a critical move, Senate GOP leaders have successfully defended Trump's tariffs, with Vice President Vance casting the tie-breaking vote. Despite economic contraction, the bill to rein in tariffs was rejected, signaling ongoing support for Trump's trade policies.
